Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: Preliminary results

International Journal of Tuberculosis and Lung Disease

Volumn 5, Issue 6, 2001, Pages 559-563

  Singla, R ^a   Gupta, S ^a   Gupta, R ^a   Arora, V K ^a  

^a LRS Institute of TB and Respiratory Diseases   (India)

Author keywords

Drug resistance; Quinolones; Sparfloxacin; Tuberculosis

Indexed keywords

ETHIONAMIDE; KANAMYCIN; SPARFLOXACIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADULT; AGEUSIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; NEURITIS; PHOTOTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; SPUTUM SMEAR; SYMPTOM; THORAX RADIOGRAPHY; VOMITING; WORLD HEALTH ORGANIZATION;

ADULT; ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; CULTURE MEDIA; DERMATITIS, PHOTOTOXIC; DRUG THERAPY, COMBINATION; ETHIONAMIDE; FLUOROQUINOLONES; HUMANS; KANAMYCIN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 0034950868     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. The clinical use of fluoroquinolones for the treatment of mycobacterial diseases
2. Fluoroquinolones: A new treatment for tuberculosis?
3. Outcome of pulmonary tuberculosis patients treated with ofloxacin/levofloxacin-containing regimens
4. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages
5. In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis
6. Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice
7. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex
8. Ambulatory regimen with sparfloxacin and combined old antituberculosis drugs plus surgery for treatment of multidrug-resistant tuberculosis
9. Use of sparfloxacin for the treatment of multidrug-resistant pulmonary tuberculosis
10. Early experience with sparfloxacin in tuberculosis
11. Comparative penetration of selective fluoroquinolones into respiratory tract fluids and tissues
12. Toxicity of quinolones
13. The link between sunshine and phototoxicity of sparfloxacin